Erlotinib and Temsirolimus for Solid Tumors
|2||Active, not recruiting||
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)
† Study has passed its completion date and status has not been verified in more than two years.